Suchergebnisse - "Cheng, Hua"

PubPharm (18)

1

Synthesis and evaluation of the epithelial-to- mesenchymal inhibitory activity of indazole-derived imidazoles as dual ALK5/p38α MAP inhibitors

enthalten in: European journal of medicinal chemistry | 2021

von Liu, Y. | Guo, Z. | Wang, J. | +6

2

A meta-analysis of adjuvant EGFR-TKIs for patients with resected non-small cell lung cancer

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2019

von Cheng, H. | Li, X. | Wang, X. | +5

3

Design, synthesis, and antifibrosis evaluation of 4-(benzo-[c][1,2,5]thiadiazol-5-yl)-3(5)-(6-methyl- pyridin-2-yl)pyrazole and 3(5)-(6-methylpyridin- 2-yl)-4-(thieno-[3,2,-c]pyridin-2-yl)pyrazole derivatives

enthalten in: European journal of medicinal chemistry | 2019

von Zhu, W. | Cui, B. | Wang, H. | +4

4

Impact of clinical parameters and systemic inflammatory status on epidermal growth factor receptor-mutant non-small cell lung cancer patients readministration with epidermal growth factor receptor tyrosine kinase inhibitors

enthalten in: BMC cancer | 2016

von Chen, Y. | Lai, C. | Rau, K. | +15

5

Advanced non-Small cell lung cancer patients at the extremes of age in the era of epidermal growth factor receptor tyrosine kinase inhibitors

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2016

von Chen, Y. | Lai, C. | Rau, K. | +16

6

Novel oral transforming growth factor-β signaling inhibitor EW-7197 eradicates CML-initiating cells

enthalten in: Cancer science | 2016

von Naka, K. | Ishihara, K. | Jomen, Y. | +16

7

Synthesis and biological evaluation of 5-(fluoro-substituted-6-methylpyridin-2-yl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)imidazoles as inhibitors of transforming growth factor-β type I receptor kinase

enthalten in: Bioorganic & medicinal chemistry letters | 2015

von Krishnaiah, M. | Jin, C. | Sheen, Y. | +1

8

Discovery of N-((4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl)methyl)-2-fluoroaniline (EW-7197) : a highly potent, selective, and orally bioavailable inhibitor of TGF-β type I receptor kinase as cancer immunotherapeutic/antifibrotic agent

enthalten in: Journal of medicinal chemistry | 2014

von Jin, C. | Krishnaiah, M. | Sreenu, D. | +8

9

4-([1,2,4]Triazolo[1,5-a]pyridin-6-yl)-5(3)-(6-methylpyridin-2-yl)imidazole and -pyrazole derivatives as potent and selective inhibitors of transforming growth factor-β type I receptor kinase

enthalten in: Bioorganic & medicinal chemistry | 2014

von Jin, C. | Krishnaiah, M. | Sreenu, D. | +5

10

Targeting mTOR to overcome epidermal growth factor receptor tyrosine kinase inhibitor resistance in non-small cell lung cancer cells

enthalten in: PloS one | 2013

von Fei, S. | Zhang, X. | Dong, S. | +7